| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| |
| | | UNI - EN REPORT No | 100 | / | 2012 |
| | |
| | Date of issue: | 2012-10-11 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Current report 100 buy back 11102012 | |
| | Official market - legal basis | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from 4 October 2012 up to and including 10 October 2012 the Company bought 1020 own shares representing 0.00077% of the share capital of the Company, to the total value of BGN 2432.6 on the Bulgarian Stock Exchange. The average price per share was BGN 2.38.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.
The total number of own shares after these transactions is 3207275, representing 2.43% of the share capital of the Company.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | Current report 100 buy back 11102012.doc | Current report 100 buy back 11102012 | |
